Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Piper Sandler

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

Benzinga

Piper Sandler Lists What Could Go Right For Bill.Com

Piper Sandler analyst Brent Bracelin maintained Bill.Com Holdings, Inc (NYSE:BILL) with an Overweight and lowered the price target from $300 to $205 (92.4% upside). After six months of fielding investor questions, Piper Sandler published a new 'what could go right?' report series. The report involved in-person meetings with senior leadership to understand better how different cloud business…

Benzinga

10 Biggest Price Target Changes For Tuesday

Needham reduced WalkMe Ltd. (NASDAQ: WKME) price target from $40 to $20. WalkMe shares dropped 8.1% to close at $12.20 on Monday.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Piper Sandler Maintains Neutral Rating for Marathon Petroleum: Here's What You Need To Know

Piper Sandler has decided to maintain its Neutral rating of Marathon Petroleum (NYSE:MPC) and raise its price target from $96.00 to $106.00. Shares of Marathon Petroleum are trading up 2.15% over the last 24 hours, at $98.64 per share.

Benzinga

Piper Sandler Maintains Overweight Rating for Altimmune: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of Altimmune (NASDAQ:ALT) and lower its price target from $34.00 to $25.00. Shares of Altimmune are trading down 0.57% over the last 24 hours, at $5.26 per share. A move to $25.00 would account for a 375.29% increase from the current…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022

Benzinga

Piper Sandler Maintains Neutral Rating for Pacific Biosciences: Here's What You Need To Know

Piper Sandler has decided to maintain its Neutral rating of Pacific Biosciences (NASDAQ:PACB) and lower its price target from $13.00 to $6.00. Shares of Pacific Biosciences are trading down 2.74% over the last 24 hours, at $5.68 per share.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

10 Biggest Price Target Changes For Thursday

Wells Fargo cut the price target on Ford Motor Company (NYSE: F) from $24 to $12. Ford shares fell 2.8% to $12.47 in pre-market trading.

Benzinga

Piper Sandler Maintains Overweight Rating for Beauty Health: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of Beauty Health (NASDAQ:SKIN) and lower its price target from $26.00 to $24.00. Shares of Beauty Health are trading down 0.76% over the last 24 hours, at $12.40 per share.

Benzinga

Why These Analysts Cut Unity Software Price Target By 50%

Shares of Unity Software Inc (NYSE: U) tanked more than 30% after the company reported a wider-than-expected net loss for the first quarter and issued weak revenue guidance.

Benzinga

What Are Whales Doing With Palantir Technologies

Someone with a lot of money to spend has taken a bearish stance on Palantir Technologies (NYSE:PLTR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022

Upgrades

Benzinga

'Still A Second-Half Story': Twilio Analysts React To Mixed Q1 Earnings

Twilio Inc (NYSE: TWLO) shares dropped 2.7% on Thursday after the company reported conservative second-quarter guidance.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Benzinga

Piper Sandler Maintains Overweight Rating for eBay: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of eBay (NASDAQ:EBAY) and lower its price target from $68.00 to $63.00. Shares of eBay are trading down 9.28% over the last 24 hours, at $49.37 per share. A move to $63.00 would account for a 27.61% increase from the current…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022

Upgrades

Benzinga

Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues

Masimo Corp's (NASDAQ:MASI) Q1 revenue increased 1.7% Y/Y (+3.2% on a constant currency basis) to $304.2 million, beating the consensus of $303.83 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 75,700 in Q1 of 2022. The adjusted operating margin remained unchanged at 22.9%. The company reported…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022

Upgrades

Benzinga

Piper Sandler Downgrades Kellogg And Tyson Foods

Consumers are cutting back spending, even on basic goods, due to elevated levels of inflation, according to Piper Sandler.

Benzinga

Piper Sandler Maintains Overweight Rating for ZoomInfo Technologies: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of ZoomInfo Technologies (NASDAQ:ZI) and lower its price target from $75.00 to $65.00. Shares of ZoomInfo Technologies are trading up 3.7% over the last 24 hours, at $51.02 per share.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Upgrades

Benzinga

JPMorgan Chase Whale Trades For May 02

Someone with a lot of money to spend has taken a bearish stance on JPMorgan Chase (NYSE:JPM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Piper Sandler Downgrades Territorial Bancorp: Here's What You Need To Know

Piper Sandler downgraded its rating of Territorial Bancorp (NASDAQ:TBNK) to Underweight with a price target of $24.00, changing its price target from $27.00 to $24.00. Shares of Territorial Bancorp are trading up 0.13% over the last 24 hours, at $22.74 per share.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022

Upgrades

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.